A Phase 2 Clinical Trial of AR1004 in Patients with Mild Cognitive Impairment

Authors
Category Primary study
ConferenceAlzheimer's Association International Conference, AAIC 2024
Year 2024
This article has no abstract
Epistemonikos ID: a28a44903c158376a6b60cd47db1c38db35b391c
First added on: Oct 25, 2025